Alpha-amylase variants and polynucleotides encoding same

Patent metadata

Field	Value
Publication number	US-9416355-B2
Application number	US-201113515437-A
Country	US
Kind code	B2
Filing date	Jan 4, 2011
Priority date	Jan 4, 2010
Publication date	Aug 16, 2016
Grant date	Aug 16, 2016

Abstract

The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.

First claim

What is claimed is:

1. An isolated variant alpha-amylase, comprising the set of substitutions at positions E129V+K177L+R179E and at least one further amino acid substitution at a position corresponding to any of positions 59, 89, 91, 96, 108, 112, 157, 165, 166, 168, 171, 180, 181, 184, 208, 220, 224, 242, 254, 269, 270, 274, 276, 281, 284, 416, and 427, wherein the variant has at least 90% and less than 100% sequence identity with the mature polypeptide of SEQ ID NO: 1, wherein the variant has alpha-amylase activity.

2. The variant of claim 1 , which comprises
a substitution at a position corresponding to position 59 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, or Tyr;
a substitution at a position corresponding to position 89 with Ala, Arg, Asn, Asp, Cys, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 91 with Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 96 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 108 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 112 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 157 with Ala, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 165 Ala, Arg, Asn, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 166 Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Tyr, or Val;
a substitution at a position corresponding to position 168 with Ala, Arg, Asn, Asp, Cys, Gln, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 171 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 180 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 181 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 184 with Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 208 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 220 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 224 with Ala, Arg, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 242 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 254 with Ala, Arg, Asn, Asp, Cys, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 269 with Ala, Arg, Asn, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 270 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 274 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 276 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, or Val;
a substitution at a position corresponding to position 281 with Ala, Arg, Asn, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 284 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Phe, Pro, Ser, Thr, Trp, Tyr, or Val;
a substitution at a position corresponding to position 416 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val; and/or
a substitution at a position corresponding to position 427 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, or Val.

3. The variant of claim 1 , has at least 95% and less than 100% sequence identity, with the mature polypeptide of SEQ ID NO:1.

4. The variant of claim 1 , wherein the variant has 3-20 amino acid substitutions.

5. The variant of claim 1 , wherein the variant has 3, 4, 5, 6, 7, 8, 9 or 10 amino acid substitutions.

6. The variant of claim 1 , which further comprises a deletion at one or more positions corresponding to positions 180, 181 and 182.

7. The variant of claim 1 , which further comprises an amino acid substitution at a position corresponding to position 193.

8. The variant of claim 1 , which further comprises a deletion at one or more positions corresponding to positions 376 or 377.

9. The variant of claim 1 , which is a variant of a parent alpha-amylase having at least 98% sequence identity with the mature polypeptide of SEQ ID NO:1, which has alpha-amylase activity.

10. The variant of claim 9 , wherein the parent alpha-amylase has at least 99% sequence identity with the mature polypeptide of SEQ ID NO:1.

11. The variant of claim 9 , wherein the parent alpha-amylase is a fragment of the amino acid sequence of the mature polypeptide of SEQ ID NO:1, wherein the fragment has alpha-amylase activity.

12. The variant of claim 9 , which has a sequence identity of at least 99%, but less than 100%, to the amino acid sequence of the parent alpha-amylase.

13. A detergent composition comprising a variant of claim 1 and a surfactant.

14. A method of producing liquefied starch, comprising liquefying a starch-containing material with a variant of claim 1 .

15. A process of producing a fermentation product, comprising
a. liquefying a starch-containing material with a variant of claim 1 to produce a liquefied mash;
b. saccharifying the liquefied mash to produce fermentable sugars; and
c. fermenting the fermentable sugars in the presence of a fermenting microorganism.

16. A process of producing a fermentation product, comprising contacting a starch substrate with variant of claim 1 , a glucoamylase, and a fermenting microorganism.

Assignees

• Andersen Carsten
• Deinhammer Randall
• Poulsen Thomas Agersten
• Toscano Miguel Duarte
• Hansen Peter Kamp
• Friis-Madsen Henrik
• Viksoe-Nielsen Anders
• Larsen Signe Eskildsen
• Christensen Lars L H
• Novozymes North America Inc
• Novozymes As

Inventors

• Andersen Carsten
• Deinhammer Randall
• Poulsen Thomas Agersten
• Toscano Miguel Duarte
• Hansen Peter Kamp
• Friis-Madsen Henrik
• Viksoe-Nielsen Anders
• Larsen Signe Eskildsen
• Christensen Lars L H

Classifications

• C11D3/38681

  Chemically modified or immobilised enzymes · CPC title

• C11D3/386

  Preparations containing enzymes {, e.g. protease or amylase} · CPC title

• C12P19/04

  Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds · CPC title

• C12N9/2417 Primary

  from microbiological source · CPC title

• C12N15/8257

  for the production of primary gene products, e.g. pharmaceutical products, interferon · CPC title